# Filing Detail

Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001213900-21-005637
Filing Date
2021-02-01
Accepted
2021-02-01 11:52:11
Documents
15

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | PROSPECTUS | ea134268-424b4_nlspharma.htm | 424B4 | 1978762
2 | GRAPHIC | image_001.jpg | GRAPHIC | 14073
3 | GRAPHIC | image_004a.jpg | GRAPHIC | 30789
4 | GRAPHIC | image_005.jpg | GRAPHIC | 34402
5 | GRAPHIC | image_006.jpg | GRAPHIC | 14916
6 | GRAPHIC | image_007.jpg | GRAPHIC | 17745
7 | GRAPHIC | image_008.jpg | GRAPHIC | 11253
8 | GRAPHIC | image_009.jpg | GRAPHIC | 22650
9 | GRAPHIC | image_010.jpg | GRAPHIC | 15414
10 | GRAPHIC | image_011.jpg | GRAPHIC | 18536
11 | GRAPHIC | image_012.jpg | GRAPHIC | 23274
12 | GRAPHIC | image_013.jpg | GRAPHIC | 46910
13 | GRAPHIC | image_014.jpg | GRAPHIC | 13369
14 | GRAPHIC | image_015.jpg | GRAPHIC | 46220
15 | GRAPHIC | image_016.jpg | GRAPHIC | 95983
| Complete submission text file | 0001213900-21-005637.txt |  | 2540056

Mailing Address ALTER POSTPLATZ 2 STANS V8 CH-6370
Business Address ALTER POSTPLATZ 2 STANS V8 CH-6370 41-41-618-80-00
NLS Pharmaceutics Ltd. (Filer) CIK: 0001783036 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-236797 | Film No.: 21575552
SIC: 2834 Pharmaceutical Preparations